Elsevier Publishes Six New Books in Biomedical and Life Sciences

New translational book content serving the needs of researchers will be featured at experimental Biology conference April 26-30, 2014

Waltham, MA, April 28, 2014

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of six new books that serve the needs of researchers and academics with an emphasis on the translational level, including the new book Cellular and Molecular Pathobiology of Cardiovascular Disease edited by Monte Willis, Jonathon Homeister and James Stone. Topics covered in the six books are, among others, pathology, nutrition, molecular biology, drug discovery and cardiovascular research. All of the books will be featured at the Experimental Biology conference April 26-30 in San Diego at Elsevier’s booth #710.

Cellular and Molecular Pathobiology of Cardiovascular Disease offers translational coverage of cardiovascular physiology, pathophysiology and molecular pathology. It provides insight on how clinical observations and practices can feed back into the research cycle. This feedback helps researchers develop more targeted genomic and proteomic insights into the mechanisms of cardiovascular disease. The book is uniquely geared toward a wide audience of graduate students and post-doctoral fellows in pathology, physiology, genetics, and pharmacology, as well as medical residents in pathology, laboratory medicine, internal medicine, cardiovascular surgery and cardiology.

Editor Monte S. Willis, MD, PhD, is affiliated with the University of North Carolina in Chapel Hill (UNC/Chapel Hill) where he leads a research team studying the role of the ubiquitin proteasome system in metabolism and the pathophysiology of cardiac disease. Dr. Willis has published more than 180 manuscripts in clinical, translational and the basic sciences, and edited multiple medical textbooks. Co-editor Jonathon W. Homeister, MD, PhD, is a member of the McAllister Heart Institute and Director of the Molecular and Cellular Pathology Graduate Program at UNC/Chapel Hill. Co-editor James R. Stone, MD, PhD, is Head of the Cardiovascular Pathology Service at Massachusetts General Hospital, where he directs a research laboratory in the Center for Systems Biology that studies the mechanisms underlying cardiovascular diseases.

The six new biomedical and life science books, published under the Academic Press and Woodhead Publishing imprints, are:

The books are available on the Elsevier Store and on ScienceDirect, Elsevier’s full-text scientific database offering journal articles and book chapters from more than nearly 2,200 peer-reviewed journals, almost 900 serials and 25,000 book titles.

Publish with Elsevier: On Tuesday, April 29 from 1:00-2:00 p.m. PT, Elsevier will host a “Meet the Acquisition Editors” session at booth #710 for those interested in publishing with Elsevier and to answer questions regarding current projects.

At the Elsevier booth, Experimental Biology attendees can also learn more about Elsevier’s new open-access methods journal, MethodsX. The journal publishes customized scientific methods that give researchers credit for the adaptations made to existing technical protocols, making them available to the global scientific community.

---

Notes for editors
Review copies of the books are available to credentialed journalists upon request. Contact Michelle McMahon at m.mcmahon.1@elsevier.com or +1 781 663 2268.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contacts
Michelle McMahon
Publicity Manager, Science & Technology Books
Elsevier
+1 781 663 2268
m.mcmahon.1@elsevier.com